Home › Cancro del polmone non a piccole cellule › California › Glendale
Studi clinici su Cancro del polmone non a piccole cellule a Glendale, CA
9 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Glendale e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
In reclutamentoFase 2/3
- Los Angeles Cancer Network, Glendale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Oncura Health - Corporate (Central IDS & Regulatory Only), Glendale
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2
- Los Angeles Cancer Network, Glendale
- Glendale Adventist Medical Center, Glendale
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
In reclutamentoFase 1/2
- OPN Healthcare, Inc, Glendale
Pan-tumor MRD Study
In reclutamentoStudio osservazionale
- Los Angeles Cancer Network (LACN), Glendale
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
In reclutamentoFase 3
- Oncura Health d.b.a.Los Angeles Cancer Network, Glendale
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
In reclutamentoFase 3
- OPN Healthcare, Inc., Glendale
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
In reclutamentoFase 1/2
- Los Angeles Cancer Network, Glendale
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
In reclutamentoFase 2
- OPN Healthcare, Inc., Glendale
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Glendale
- Disturbo depressivo maggiore12 studi
- Depressione6 studi
- Cancro (tutti i tipi)5 studi
- Obesità5 studi
- Cancro al seno4 studi
- Cancro colorettale4 studi
- Cancro ai polmoni4 studi
- Cancro metastatico3 studi
- Malattia coronarica3 studi
- Melanoma3 studi
- Edema maculare3 studi
- Sovrappeso3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.